Table 1. Nucleotide change in CD166 positive and CD166 negative CRC and CAD generated from colon cancer mutation array test.

CRC	Mutants detected	One nucleotide change	Two nucleotide change	Total nucleotide change
CD166 positive specimens	FBXW7, TP53, KRAS	6/12 = 50.0%	0%	6
CD166 negative specimens	TP53	2/6 = 33.3%	0%	2
CAD
CD166 positive specimens	APC, KRAS, SRC, TP53, PIK3CA	16/30 = 53.3%	8/30 = 26.7%	32
CD166 negative specimens	APC	4/8 = 50.0%	0%	4
Total nucleotide change		28	16	44